Current ratio increased 34.6%
Current ratio changed +34.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
1.91→2.574 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FSLR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 1514 bp higher
Operating margin changed +1514 basis points from the comparable as-filed period.
29.22%→44.37%2 prior comparisons
Revenue decreased 22.8%
Revenue changed -22.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.6B→$1.2B2 prior comparisons
Gross margin moved 1963 bp higher
Gross margin changed +1963 basis points from the comparable as-filed period.
38.29%→57.93%2 prior comparisons
Cost of revenue decreased 47.4%
Cost of revenue changed -47.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$984.1M→$517.9M2 prior comparisons
Net income increased 25.2%
Net income changed +25.2% from the comparable as-filed period.
$455.9M→$571.1M2 prior comparisons
Operating income increased 17.2%
Operating income changed +17.2% from the comparable as-filed period.
$466.1M→$546.1M2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed -118.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
$1.1B→-$197.8M2 prior comparisons
Cash & equivalents decreased 20.9%
Cash & equivalents changed -20.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$2.0B→$1.6B4 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -103.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
$1.3B→-$42.9M2 prior comparisons
Current liabilities decreased 33.2%
Current liabilities changed -33.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$3.1B→$2.1B4 prior comparisons
Free-cash-flow proxy decreased 121.0%
Free-cash-flow proxy changed -121.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-$138.6M→-$306.2M3 prior comparisons
Operating income increased 24.6%
Operating income changed +24.6% from the comparable as-filed period.
$361.6M→$450.4M2 prior comparisons
Operating margin moved 968 bp higher
Operating margin changed +968 basis points from the comparable as-filed period.
32.96%→42.64%2 prior comparisons
Cash & equivalents increased 50.1%
Cash & equivalents changed +50.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.1B→$1.7B4 prior comparisons
Gross margin moved 1172 bp higher
Gross margin changed +1172 basis points from the comparable as-filed period.
45.56%→57.28%2 prior comparisons
Current ratio increased 32.4%
Current ratio changed +32.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
1.9→2.524 prior comparisons
Capex / revenue moved 1099 bp lower
Capex / revenue changed -1099 basis points from the comparable as-filed period.
26.26%→15.27%2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -196.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
$149.6M→-$144.9M3 prior comparisons
Capital expenditure decreased 44.0%
Capital expenditure changed -44.0% from the comparable as-filed period.
$288.1M→$161.3M3 prior comparisons
Net income increased 23.6%
Net income changed +23.6% from the comparable as-filed period.
$341.9M→$422.6M2 prior comparisons
Research & development increased 39.9%
Research & development changed +39.9% from the comparable as-filed period.
$54.5M→$76.2M2 prior comparisons
Cost of revenue decreased 24.5%
Cost of revenue changed -24.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$597.3M→$451.2M2 prior comparisons
Inventory / revenue moved 2586 bp lower
Inventory / revenue changed -2586 basis points from the comparable as-filed period.
128.88%→103.02%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.